## Blog entry by Meguid El Nahas

Anyone in the world

Prevalence of Diagnosed Cancer According to Duration of Diagnosed Diabetes and Current Insulin Use Among U.S. Adults With Diagnosed Diabetes Findings from the 2009 Behavioral Risk Factor Surveillance System

Authors :CHAOYANG LI,GUIXIANG ZHAO,XIAO-JUN WEN,EARL S. FORD, LINA S. BALLUZ,
org DIABETES CARE
Diabetes Care Publish Ahead of Print, published online January 8, 2013

this article recently published in diabetes care raises suspicious about long term insulin use in T2DM and cancer .
The aim of the study was to To determine whether longer duration of diagnosed diabetes and current insulin use are associated with increased prevalence of cancer among adults with diagnosed diabetes,
Authors analyzed a large population-based sample from the 2009 Behavioral Risk Factor Surveillance
System (BRFSS) in the U.S. The BRFSS is a standardized telephone survey that assesses key
behavioral risk factors, lifestyle habits,and chronic illnesses and conditions among adults aged $18 years in all U.S. RESULT :There were a total of 34,424 adults with diagnosed diabetes participating in the survey with the diabetes module. Of them, 8,460 had missing data on diabetes age, insulin use, and selected covariates. Among adults with diagnosed diabetes and with complete data on cancer and diabetes-related covariates (n = 25,964), there were 11,165 men (weighted percentage, 52.8%), 18,673 NH whites (65.3%), 3,575 NH blacks (16.0%), 2,348 Hispanics (13.1%), and 1,368 participants with NH other race/ ethnicity (5.6%). Approximately 4.7% of adults with diagnosed diabetes were estimated to have type 1 diabetes (n = 491 men and 721 women), 70.5% were type 2 diabeticwithout current insulin use (n = 7,820 men and 10,475 women), and 24.8% were type 2 diabetic with current insulin use (n = 2,854 men and 3,603 women). The mean age was 58.6 years (median 59.0 years). The mean age at diabetes diagnosis was 47.6 years (49.0 years). The unadjusted prevalence for cancers of all sites among men with type 2 diabetes and current insulin use was higher than those with either type 1 diabetes (P , 0.001) or those with type 2 diabetes and no current insulin use (P , 0.001) among both men and women. After adjustment for age, the difference in the prevalence estimates for cancers of all sites remained between adults with type 2 diabetes with current insulin use and those with type 2 diabetes with no current insulin use among men (P , 0.001) and women (P , 0.001). Among both men and women with type 2 diabetes, the prevalence estimates for cancers of all sites were significantly higher among those who had diabetes >15 years than among those who had diabetes ,15 years after adjustment for all selected covariates . Specifically,the prevalence was estimated to be significantly higher among adults who had diabetes$15 years for colon cancer, melanoma, nonmelanoma skin cancer, and cancer of urinary tract among men and the cancers of the breast, female reproductive tract, and skin among women than those who had diabetes ,15 years. Among both men and women with type 2 diabetes, the prevalence estimate for cancers of all sites was ~1.5 times higher among those who used insulin than those who did not use insulin after adjustment for demographic characteristics and selected health risk factors.
current insulin
use remained significantly associated with increased prevalence of cancers of all sites among both men and women and increased prevalence of skin cancer (both melanoma and nonmelanoma) among men and cancer of the reproductive tract .